摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-Ethylamino-thiophenol | 4946-23-0

中文名称
——
中文别名
——
英文名称
4-Ethylamino-thiophenol
英文别名
4-(Ethylamino)benzenethiol
4-Ethylamino-thiophenol化学式
CAS
4946-23-0
化学式
C8H11NS
mdl
——
分子量
153.248
InChiKey
OMUSVLUXQOYBJR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    10
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    13
  • 氢给体数:
    2
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    4-Ethylamino-thiophenol 在 sodium iodide sodium hydroxide 、 sodium carbonate 作用下, 以 乙醇N,N-二甲基甲酰胺 为溶剂, 反应 48.0h, 生成 N-ethyl-4-[3-[4-(2-methylphenyl)piperazin-1-yl]propylsulfanyl]aniline
    参考文献:
    名称:
    降压的1- [3-(4-取代的苯硫基)丙基] -4-(取代的苯基)哌嗪的合成和QSAR研究。
    摘要:
    合成了一系列1- [3-(4-取代的苯硫基)丙基] -4-(取代的苯基)哌嗪,并对其降压活性进行了评估。QSAR研究表明,芳基取代基的共振和疏水参数对降压活性很重要。共振参数在描述这些化合物的5-HT(2A)受体结合亲和力变化中的相似作用表明5-HT(2A)受体在介导标题化合物的降压作用中可能发挥作用。
    DOI:
    10.1016/j.bmcl.2006.12.072
点击查看最新优质反应信息

文献信息

  • PHTHALOCYANINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND OPTICAL RECORDING MEDIUM CONTAINING THE SAME
    申请人:MITSUI CHEMICALS, INC.
    公开号:EP1482013A1
    公开(公告)日:2004-12-01
    A phthalocyanine compound represented by the following general formula (I) and the mixture thereof, and an optical recording medium containing the compound/mixture in its recording layer. wherein in formula (I), M is two hydrogen atoms, a divalent metal atom, a mono-substituted trivalent metal atom, a di-substituted tetravalent metal atom, or an oxymetal, and L1, L2, L3 and L4 are each independently formula (a), formula (b), or formula (c) : in formula (a), formula (b), and formula (c), X represents a substituted or unsubstituted alkyl group, alkoxy group, alkylthio group, aryloxy group, and arylthio group, Rs are each independently a hydrogen atom, a substituted or unsubstituted alkyl group with 1-6 of total carbon numbers, a substituted or unsubstituted aryl group with 6-10 of total carbon numbers, A represents a carbonyl group, a thiocarbonyl group, a sulfone group, a sulfine group, or a carboimidoyl group, Y represents a metal compound residue, and Z represents independently a hydrogen atom, a nitro group, or a halogen atom, and at least one of L1-L4 is formula (a) or (b).
    由以下通式(I)表示的酞菁化合物及其混合物,以及在其记录层中含有该化合物/混合物的光学记录介质。 其中,在式 (I) 中,M 是两个氢原子、二价金属原子、一取代三价金属原子、二取代四价金属原子或氧金属;L1、L2、L3 和 L4 各自独立地为式 (a)、式 (b) 或式 (c) : 在式(a)、式(b)和式(c)中,X 代表取代或未取代的烷基、烷氧基、烷硫基、芳氧基和芳硫基,Rs 各自独立地为氢原子、总碳数为 1-6 的取代或未取代的烷基、A 代表羰基、硫代羰基、砜基、硫基或羧酰亚胺基,Y 代表金属化合物残基,Z 独立地代表氢原子、硝基或卤素原子,L1-L4 中至少有一个是式 (a) 或 (b)。
  • PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, DYE SOLUTION, DYE-ADSORBED ELECTRODE, AND METHOD FOR PRODUCING DYE-SENSITIZED SOLAR CELL
    申请人:FUJIFILM CORPORATION
    公开号:EP2933875B1
    公开(公告)日:2017-03-29
  • Phthalocyanine compound, process for producing the same, and optical recording medium containing the same
    申请人:Seino Kazuhiro
    公开号:US20050201265A1
    公开(公告)日:2005-09-15
    A phthalocyanine compound represented by the following general formula (I) and the mixture thereof, and an optical recording medium containing the compound/mixture in its recording layer. wherein in formula (I), M is two hydrogen atoms, a divalent metal atom, a mono-substituted trivalent metal atom, a di-substituted tetravalent metal atom, or an oxymetal, and L 1 , L 2 , L 3 and L 4 are each independently formula (a), formula (b), or formula (c): wherein X, Y, Z and R are defined.
  • SULFONAMIDE-CONTAINING LINKAGE SYSTEMS FOR DRUG CONJUGATES
    申请人:ZYMEWORKS INC.
    公开号:US20170029490A1
    公开(公告)日:2017-02-02
    Sulfonamide-containing linkage systems for release of payload compounds from an attached targeting moiety in drug conjugates. The conjugates have the formula of [(P)-(L)]m-(T), wherein (P) is a payload compound, (L) is a linker, (T) is a targeting moiety and m is an integer from 1- to 10. Also provided are pharmaceutical compositions comprising such conjugates and there use in treating cancer.
  • US7332261B2
    申请人:——
    公开号:US7332261B2
    公开(公告)日:2008-02-19
查看更多